Restaurants are creating Ozempic menus with smaller meals for people who are taking GLP-1 weight-loss drugs and have a ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

Copycats and false advertisements are also to blame for the increased threats. Stemming from social media testimonials all ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

In addition, some 25% of people taking GLP-1 drugs experience GI issues, Defnet noted, and while these primarily include ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Discover how food brands can adapt to the rising GLP-1 trend. As weight-loss drugs reshape consumer habits, learn which ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...